Royal Responses to the Covid-19 Pandemic
Rhetorica Scandinavica · 05.09.2023 · 27 (85) · 73-94
DOI: 10.52610/rhs.v27i85.87 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rhetorica Scandinavica, online erschienen am 05.09.2023. Verfasst von Jens Elmelund Kjeldsen und 2 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
This article offers a rhetorical analysis of the addresses delivered by six Northern European monarchs in response to the Covid-19 pandemic in early 2020. The analysis establishes a new genre with distinctive traits and functions: They royal crisis address. This genre has two constitutive traits: To demonstrate the seriousness of the situation and to constitute the citizens and encourage them to behave in the right way. The genre also has three optional traits: to provide thanks, to empathise with those affected, and to reassure and inspire the nation. In a national crisis such as the Covid-19 pandemic, these rhetorical functions will also be performed by national leaders, however, because of the apolitical position and charismatic and historical power of the royals in the North European monarchies the royals can perform these functions with a special authority. We describe how this is done through the five functions and through epideictic and constitutive rhetoric.
Zitieren
APA
Kjeldsen, J. E., Jong, J. D., & Atkins, J. (2023). Royal Responses to the Covid-19 Pandemic. Rhetorica Scandinavica, 27(85), 73-94. https://doi.org/10.52610/rhs.v27i85.87
Vancouver
Kjeldsen JE, Jong JD, Atkins J. Royal Responses to the Covid-19 Pandemic. Rhetorica Scandinavica. 2023;27(85):73-94. doi:10.52610/rhs.v27i85.87
BibTeX
@article{Kjeldsen2023,
author = {Kjeldsen, Jens Elmelund and Jong, Jaap De and Atkins, Judi},
title = {Royal Responses to the Covid-19 Pandemic},
journal = {Rhetorica Scandinavica},
year = {2023},
volume = {27},
number = {85},
pages = {73--94},
doi = {10.52610/rhs.v27i85.87}
}
EUVIMED